When the biochemical processes of the immune system are either misdirected or chronically turned on, inflammation can lead to adversity, including some forms of cancer. For this reason, scientists are closely studying the link between inflammatory processes and tumor formation, while others are investigating anti-inflammatory drugs as a means to prevent and treat cancer.
Researchers are delving deeper into the links between smoking and cancer, teasing out the genes and molecules involved as well as other factors that affect cancer risk.
While risk factors for breast and ovarian cancers include menopause, obesity, family history and specific genetic mutations, researchers also are looking at the role of diet in the development, as well as the treatment and prevention of these tumors.
Molecular messages and signals circulating in blood or contained in cells lining the airway can identify early stage cancer. Researchers have discovered molecular signposts pointing to the presence of cancer, and those signs can provide physicians with early and, in some cases, more specific cancer detection opportunities.
Results from a Phase III study of a new drug show promise for patients with colorectal cancer that has spread to other parts of the body, according to a study presented today during the 97th Annual Meeting of the American Association for Cancer Research.
A study led by researchers from the Howard Hughes Medical Institute has found that dasatinib provides significant benefit in chronic myeloid leukemia (CML) patients resistant to Gleevec® (imatinib), according to a study presented today during the 97th Annual Meeting of the American Association for Cancer Research.
The latest data show that COX-2 inhibitors are highly effective in preventing pre-malignant tumors of the colon, and therefore may be useful in preventing colorectal cancer among high-risk patients.
World-renowned scientists, physicians, academicians and advocates will gather for the 97th Annual Meeting of the American Association for Cancer Research (AACR), taking place April 1-5 at the Washington Convention Center, Washington, D.C.
During the past few months, funding for cancer research has received some bad news. In December 2005, the President signed the final appropriations bill for fiscal year 2006, which provided $31 million less for cancer research than the year before.
To address the unmet public need for understandable and credible information about cancer research and policy, the American Association for Cancer Research (AACR) is launching a new magazine for cancer patients, survivors, advocates, caregivers and interested physicians and scientists.
Each year at its Annual Meeting, the American Association for Cancer Research gives special recognition to distinguished individuals whose efforts and dedication have helped to increase awareness about the importance of cancer research.
Bernard Fisher, M.D., the renowned clinical cancer researcher whose career has been dedicated toward improving survival as well as quality of life for women with breast cancer, will receive the American Association for Cancer Research Award for Lifetime Achievement in Cancer Research.
Leading scientists whose work in research laboratories, universities and medical centers is helping to understand and eradicate cancer will be recognized April 1-5, 2006, by the American Association for Cancer Research (AACR) at its 97th Annual Meeting in Washington, D.C.
The American Association for Cancer Research (AACR) offers a number of grants for cancer researchers at various stages in their careers to foster the development of the most promising scientists.
Tadatsugu Taniguchi, Ph.D., professor and chairman of the Department of Immunology, University of Tokyo, Japan, is the recipient of the 10th annual Pezcoller Foundation-American Association for Cancer Research International Award for Cancer Research.
To provide some enlightenment about cancer research as a career option, the American Association for Cancer Research will host a series of special programs for young scientists at the 97th Annual Meeting.
Olufunmilayo I. Olopade, M.D., director of the Center for Clinical Cancer Genetics at the University of Chicago Medical Center, is the inaugural recipient of the AACR-Minorities in Cancer Research-Jane Cooke Wright Lectureship.
Three Scholar Awards programs will provide scientists traditionally underrepresented in cancer research with financial support to participate in the premier international meeting in the field.
The American Association for Cancer Research, the world's oldest and largest organization dedicated to cancer research, enthusiastically supports the nomination of Andrew von Eschenbach as new commissioner of the U.S. Food and Drug Administration.
Capsaicin, the stuff that turns up the heat in jalapeños, not only causes the tongue to burn, it also drives prostate cancer cells to kill themselves.
In a group of high-risk patients, a test that examined DNA from cells expelled in sputum for evidence of "silenced" genes correctly identified the majority of patients who were later diagnosed with lung cancer.
William N. Hait, M.D., Ph.D., director of The Cancer Institute of New Jersey, New Brunswick, N.J., will become president-elect of the American Association for Cancer Research effective April 3, 2006, at the 97th AACR Annual Meeting in Washington, D.C.
Two researchers whose pivotal discoveries have advanced progress against cancer by revealing vital information about the nature, origins and treatment of the disease are being honored with the 2006 Landon-AACR Prizes for Basic and Translational Cancer Research.
The AACR and the Littlefield 2000 Trust have entered into a new partnership to establish the Jeannik M. Littlefield-AACR Grants in Metastatic Colon Cancer Research.
David Irwin, Ph.D., has joined the American Association for Cancer Research as Managing Director of the Science and Education Division. This newly created position will oversee the association's activities in program development and administration.
The cosmetic treatment Botox may have a new use as an adjuvant to cancer therapy, providing an open door for chemotherapy and radiation treatments, according to a study.
American Association for Cancer Research enthusiastically supports the new guidelines announced today by the U.S. Food and Drug Administration, whose primary goal is to streamline the earliest phases of clinical research for new medical treatments.
A vast code, invisible to the DNA sequencing effort that constituted the Human Genome Project, is rapidly being shown to play a direct role in human health. This "epigenome" consists of chemical "amendments" that dangle like charms on a bracelet from the linear string of letters that spell out the genetic code.
Scientists have found some additional evidence that environmental exposure to polychlorinated biphenyls (PCBs) may be associated with non-Hodgkin lymphoma, according to a study.
They're but a tiny speck, existing in a variety of forms: particles, tubes, shells, even a soccerball-like shape. They also share a common prefix: "nano," connoting their size, a billionth of a meter or roughly 25-millionth of an inch.
A second look at compounds and drugs, some previously used to treat illness and conditions ranging from malaria to contraception, is giving new life to several abandon therapies and new applications for existing drugs.
During the past decade, several new drugs have been approved that target specific genes and molecules, increasing survival for many cancer patients. Not only are these drugs often more effective than the current standards of care, they also carry an added benefit of fewer side effects.
Cancer researchers wielding opportunistic bacteria, vaccines, electric pulses, nano buckeyballs, and designer agents that enter the brain are being featured in a "Novel Approaches" press conference at the Molecular Targets and Cancer Therapeutics International Conference.
Critical innovations and new knowledge are now emerging from the laboratories of universities, medical centers and pharmaceutical companies worldwide, offering the prospect of a new generation of drugs capable of destroying cancer cells with pinpoint accuracy, without damaging adjacent normal cells.
Critical innovations and new knowledge are now emerging from the laboratories of universities, medical centers and pharmaceutical companies worldwide, offering the prospect of a new generation of drugs capable of destroying cancer cells with pinpoint accuracy, without damaging adjacent normal cells.
According to the U.S. Centers for Disease Control and Prevention, nearly one-fourth of Americans are smokers. That's more than 60 million people who are at increased for lung cancer, the leading cause of cancer-related deaths nationwide.
Since smoking became popular in America in the 1930s, lung cancer rates have continued to climb. Today, it is still the leading cause of cancer-related deaths, with totals more than the other five leading cancers combined.
There are a number of things people are told to do to prevent cancer "“ eat well, exercise, don't smoke. However, despite these obvious preventive measures, many individuals will develop the disease.
The active metabolite of vitamin D, calcitriol, and other vitamin D analogs are promising chemopreventive agents that may prevent prostate cancer, according to a study.
Updated data from a study on a promising new vaccine against a pre-cancerous cervical virus shows superior efficacy in preventing cervical pre-cancers and non-invasive cervical cancer, according to a study.
In the high-tech 21st century, the most rudimentary natural products continue to reveal exciting ant-cancer properties to scientists, offering people relatively simple ways to help protect themselves from the disease.
Leading cancer researchers will convene at the 4th Annual Frontiers in Cancer Prevention Research meeting of the American Association for Cancer Research, the premier gathering of its kind in the world, which features the latest developments in cancer prevention research.
US Senator Arlen Specter will be honored with the AACR Public Service Award for his tireless efforts to strengthen the nation's biomedical research capability. The Award ceremony will take place at the "One World, One Quest" gala.
A team of 10 cyclists under the banner of the American Association for Cancer Research (AACR), based in Philadelphia, Pa., will join Lance Armstrong for this year's Tour of Hope.
The American Association for Cancer Research (AACR) extends its thoughts and heartfelt sympathies to all the citizens of New Orleans and other Gulf Coast communities as they rebuild their lives in the aftermath of Hurricane Katrina.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right